FindTrial
Sign In

An evidence-based study on the correlation between dyslipidemia and osteoporosis integrating Chinese and Western medicine

An evidence-based study of integrated traditional Chinese and western medicine on diseases of glucose and lipid metabolism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051370
Enrollment
Unknown
Registered
2021-09-21
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Dyslipidemia group:None
Non-dyslipidemia group:None

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1.Postmenopausal women; 2.Aged 45 to 65 years; 3.T-value of bone density measurement>-2.5; 4.Sign the informed consent form, and the respondent voluntarily participates in this survey.

Exclusion criteria

Exclusion criteria: 1.People who have had fragility fractures in the past; 2.People who suffer from mental illness or who cannot cooperate to complete the study.

Design outcomes

Primary

MeasureTime frame
Demographic general information;Complications and main drug use;Osteoporosis risk assessment Scale and number of fractures;Traditional Chinese medicine syndrome judgment;Bone mass assessment and clinical physicochemical index information;Quality of life scale;—

Countries

China

Contacts

Public ContactWei Xu

Wangjing Hospital, China Academy of Chinese Medical Sciences

weixu.007@163.com+86 13488716557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026